# The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)

> **NCT00131287** · PHASE3 · COMPLETED · sponsor: **ECbiotech Taiwan** · enrollment: 108 (—)

## Conditions studied

- Diabetes Mellitus, Type II

## Interventions

- **DRUG:** Extract of Agaricus blazei Murill

## Key facts

- **NCT ID:** NCT00131287
- **Lead sponsor:** ECbiotech Taiwan
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2006-12
- **Target enrollment:** 108 (—)
- **Last updated:** 2010-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00131287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00131287, "The Supplementary Effects of the Extract of Agaricus Blazei Murril on Type II Diabetes Mellitus (DM)". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00131287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*